Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Kohler

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Western Journal of Emergency Medicine|January 2, 2014
Evolution of a round pneumoniaMatthew Silver, Steven Kohler
Current Cancer Drug Targets|July 4, 2017
Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T CellsTiantian Zhang, Dennis H Kordish, Yogesh R Suryawanshi, et al.
Medical Oncology (Northwood, London, England)|May 4, 2017
T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumorsYogesh R Suryawanashi, Tiantian Zhang, Helene M Woyczesczyk, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Western Journal of Emergency Medicine|January 2, 2014
Evolution of a round pneumoniaMatthew Silver, Steven Kohler
Current Cancer Drug Targets|July 4, 2017
Oncolytic Tanapoxvirus Expressing Interleukin-2 is Capable of Inducing the Regression of Human Melanoma Tumors in the Absence of T CellsTiantian Zhang, Dennis H Kordish, Yogesh R Suryawanshi, et al.
Medical Oncology (Northwood, London, England)|May 4, 2017
T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumorsYogesh R Suryawanashi, Tiantian Zhang, Helene M Woyczesczyk, et al.
Pageof 1